AZN
AstraZeneca PLC
Stock
$156.90−0.80 (−0.51%)Close Oct 2, 2026
- Operating income, 2025
- $13.7B
- YoY, 2025
- +37.4%
- 5-year CAGR
- +21.6%
- 10-year CAGR
- +12.8%
Operating income
Operating income by fiscal year
| Period | Operating income | YoY |
|---|---|---|
| 2025 | $13.7B | +37.4% |
| 2024 | $10.0B | +22.1% |
| 2023 | $8.2B | +118.1% |
| 2022 | $3.8B | +255.8% |
| 2021 | $1.1B | −79.5% |
| 2020 | $5.2B | +76.5% |
| 2019 | $2.9B | −13.7% |
| 2018 | $3.4B | −7.9% |
| 2017 | $3.7B | −25.0% |
| 2016 | $4.9B | +19.2% |
| 2015 | $4.1B | — |